advertisement
11.4 Prostaglandins (16)
Showing records 1 to 16
Display all abstracts in classification 11.4 Prostaglandins
Search within classification 11.4 Prostaglandins24835 Ocular pharmacokinetics and hypotensive activity of PF-04475270, an EP4 prostaglandin agonist in preclinical models
Prasanna G; Fortner J; Xiang C; Zhang E; Carreiro S; Anderson S; Sartnurak S; Wu G; Gukasyan H; Niesman M
Experimental Eye Research 2009; 89: 608-617
24992 Changes in optic nerve head blood flow induced by the combined therapy of latanoprost and beta blockers
Sugiyama T; Kojima S; Ishida O; Ikeda T
Acta Ophthalmologica 2009; 87: 797-800
24533 The histopathological examination of mice tissues after the treatment with new synthesized prostamides with antiglaucoma action
Udeanu DI; Enache M; Mihele D; Cocu F
Farmacia 2009; 57: 315-320
24781 Effect of bimatoprost, latanoprost, and unoprostone on matrix metalloproteinases and their inhibitors in human ciliary body smooth muscle cells
Ooi YH; Oh DJ; Rhee DJ
Investigative Ophthalmology and Visual Science 2009; 50: 5259-5265
24956 Topical prostaglandin analogues do not affect selective laser trabeculoplasty outcomes
Singh D; Coote MA; O'Hare F; Walland MJ; Ghosh S; Xie J; Ruddle JB; Crowston JG
Eye 2009; 23: 2194-2199
24634 Intraocular pressure control among patients transitioned from latanoprost to travoprost at a Veterans Affairs Medical Center Eye Clinic
McKinley SH; Singh R; Chang PT; Gross RL; Orengo-Nania S
Journal of Ocular Pharmacology and Therapeutics 2009; 25: 153-157
24816 Efficacy and safety of bimatoprost as replacement for latanoprost in patients with glaucoma or ocular hypertension: a uniocular switch study
Casson RJ; Liu L; Graham SL; Morgan WH; Grigg JR; Galanopoulos A; Crawford A; House PH
Journal of Glaucoma 2009; 18: 582-588
24527 Effects of travoprost in the treatment of open-angle glaucoma or ocular hypertension: A systematic review and meta-analysis
Cheng J-W; Xi G-L; Wei R-L; Cai J-P; Li Y
Current Therapeutic Research - Clinical and Experimental 2009; 70:
24737 Comparison of travoprost and timolol in patients with primary open angle glaucoma and ocular hypertension
Zhao W-J
International Journal of Ophthalmology 2009; 9: 1753-1754
24733 Clinical research on treatment of travoprost combined with brinzolamide for primary open angle glaucoma or ocular hypertension
Wang J-P; Zhang D-X; Ma Y; Che X-Y
International Journal of Ophthalmology 2009; 9: 1510-1513
24838 Tafluprost protects rat retinal ganglion cells from apoptosis in vitro and in vivo
Kanamori A; Naka M; Fukuda M; Nakamura M; Negi A
Graefe's Archive for Clinical and Experimental Ophthalmology 2009; 247: 1353-1360
24688 Prostaglandin Pathway Gene Therapy for Sustained Reduction of Intraocular Pressure
Barraza RA; McLaren JW; Poeschla EM
Molecular Therapy 2010; 18: 491-501
24861 Xal-Ease(R): impact of an ocular hypotensive delivery device on ease of eyedrop administration, patient compliance, and satisfaction
Nordmann JP; Baudouin C; Bron A; Denis P; Rouland JF; Sellem E; Renard JP
European Journal of Ophthalmology 2009; 19: 949-956
24647 Treatment persistency of xalatan-xalacom, lumigan ganfort and travatan-duotrav: An analysis conducted on the United-Kingdom general practitioner research database
Berdeaux G; Lafuma A; Robert J
Value in Health 2009; 12: A452
24632 The impact of ocular adverse effects in patients treated with topical prostaglandin analogs: Changes in prescription patterns and patient persistence
Zimmerman TJ; Hahn SR; Gelb L; Tan H; Kim EE
Journal of Ocular Pharmacology and Therapeutics 2009; 25: 145-152
24659 Cost effectiveness analysis of tafluprost compared with latanoprost on the treatment of primary open angle glaucoma in South Korea
Song HJ; Kang SH; Heo JH; Lee EK
Value in Health 2009; 12: A456-A457